These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1652048)

  • 1. Opioids regulate the release of human chorionic gonadotropin hormone from trophoblast tissue.
    Cemerikic B; Cheng J; Agbas A; Ahmed MS
    Life Sci; 1991; 49(11):813-24. PubMed ID: 1652048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity and potency of opioid peptides in regulating human chorionic gonadotropin release from term trophoblast tissue.
    Cemerikic B; Schabbing R; Ahmed MS
    Peptides; 1992; 13(5):897-903. PubMed ID: 1362265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids regulation of human chorionic gonadotropin release from trophoblast tissue is mediated by gonadotropin releasing hormone.
    Cemerikic B; Zamah R; Ahmed MS
    J Pharmacol Exp Ther; 1994 Feb; 268(2):971-7. PubMed ID: 8114013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of L-type calcium channels associated with kappa opioid receptors in human placenta.
    Cemerikic B; Zamah R; Ahmed MS
    J Mol Neurosci; 1998 Jun; 10(3):261-72. PubMed ID: 9770647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory activity of mu- and kappa-selective opioid agonists.
    Taub DD; Eisenstein TK; Geller EB; Adler MW; Rogers TJ
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):360-4. PubMed ID: 1846441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endorphins and food intake: kappa opioid receptor agonists and hyperphagia.
    Cooper SJ; Jackson A; Kirkham TC
    Pharmacol Biochem Behav; 1985 Nov; 23(5):889-901. PubMed ID: 2867562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
    Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
    Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
    Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential antagonism of the rate-decreasing effects of kappa-opioid receptor agonists by naltrexone and norbinaltorphimine.
    Powell KR; Holtzman SG
    Eur J Pharmacol; 1999 Jul; 377(1):21-8. PubMed ID: 10448921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
    Craft RM; Dykstra LA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):327-33. PubMed ID: 1309876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
    Lohmann AB; Welch SP
    Eur J Pharmacol; 1999 Dec; 385(2-3):119-27. PubMed ID: 10607867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats.
    Takemori AE; Schwartz MM; Portoghese PS
    J Pharmacol Exp Ther; 1988 Dec; 247(3):971-4. PubMed ID: 2849679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereospecific inhibition of gastrointestinal transit by kappa opioid agonists in mice.
    Ramabadran K; Bansinath M; Turndorf H; Puig MM
    Eur J Pharmacol; 1988 Oct; 155(3):329-31. PubMed ID: 2853069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of methadone use during pregnancy on human placental opioid receptors.
    Ahmed MS; Cemerikic B; Mou S; Agbas A
    Membr Biochem; 1993; 10(2):91-8. PubMed ID: 8395641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels.
    Hayes AG; Stewart BR
    Eur J Pharmacol; 1985 Oct; 116(1-2):75-9. PubMed ID: 2996912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kappa-opioid agonists do not inhibit adenylate cyclase.
    Makimura M; Murakoshi Y
    J Pharmacobiodyn; 1989 Mar; 12(3):125-31. PubMed ID: 2547926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sufentanil, morphine, met-enkephalin, and kappa-agonist (U-50,488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions.
    Chang HM; Berde CB; Holz GG; Steward GF; Kream RM
    Anesthesiology; 1989 Apr; 70(4):672-7. PubMed ID: 2467589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. kappa-opioid receptor expression defines a phenotypically distinct subpopulation of astroglia: relationship to Ca2+ mobilization, development, and the antiproliferative effect of opioids.
    Gurwell JA; Duncan MJ; Maderspach K; Stiene-Martin A; Elde RP; Hauser KF
    Brain Res; 1996 Oct; 737(1-2):175-87. PubMed ID: 8930364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual differences in kappa opioid receptor-mediated regulation of tuberoinfundibular dopaminergic neurons.
    Manzanares J; Wagner EJ; LaVigne SD; Lookingland KJ; Moore KE
    Neuroendocrinology; 1992 Mar; 55(3):301-7. PubMed ID: 1323802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.